The invention pertains to certain composite materials featuring strong direct bonds between certain fluoropolymers and polyamides, which can be formed by using as additive certain chlorotrifluoroethylene-containing elastomers, in an ionic curable blend.

The invention pertains to certain composite materials featuring strong direct bonds between certain fluoropolymers and polyamides, which can be formed by using as additive certain chlorotrifluoroethylene-containing elastomers, in an ionic curable blend.

A biocompatible membrane composite including a cell impermeable layer and a mitigation layer is provided. The cell impermeable layer is impervious to vascular ingrowth and prevents cellular contact from the host. Additionally, the mitigation layer includes solid features. In at least one embodiment, mitigation layer has therein bonded solid features. In some embodiments, the cell impermeable layer and the mitigation layer are intimately bonded or otherwise connected to each other to form a composite layer having a tight/open structure. A reinforcing component may optionally be positioned external to or within the biocompatible membrane composite to provide support to and prevent distortion. The biocompatible membrane composite may be used in or to form a device for encapsulating biological entities, including, but not limited to, pancreatic lineage type cells such as pancreatic progenitors.

A biocompatible membrane composite including a cell impermeable layer and a mitigation layer is provided. The cell impermeable layer is impervious to vascular ingrowth and prevents cellular contact from the host. Additionally, the mitigation layer includes solid features. In at least one embodiment, mitigation layer has therein bonded solid features. In some embodiments, the cell impermeable layer and the mitigation layer are intimately bonded or otherwise connected to each other to form a composite layer having a tight/open structure. A reinforcing component may optionally be positioned external to or within the biocompatible membrane composite to provide support to and prevent distortion. The biocompatible membrane composite may be used in or to form a device for encapsulating biological entities, including, but not limited to, pancreatic lineage type cells such as pancreatic progenitors.

The present invention relates to a surface treatment composition comprising, on the basis of 100 wt % of the solid part of the composition, 20-40 wt % of a water-soluble polyurethane resin, 40-60 wt % of a silane-based sol-gel resin in which three types of silane compounds are cross-linked, 5-15 wt % of a curing agent, 0.5-1.5 wt % of a corrosion inhibitor, 0.1-1.0 wt % of a molybdenum-based compound, 1.0-3.0 wt % of a silane coupling agent; 1.0-2.0 wt % of an organometallic complex, 1.0-2.0 wt % of an acid scavenger, 0.1-1.0 wt % of an aluminum-based compound, and 1.0-2.0 wt % of a lubricant. A ternary hot-dip galvannealed steel sheet treated with a chromium-free surface treatment coating agent, according to an exemplary embodiment in the present invention, has excellent resistance to blackening, alkali and corrosion, and provides excellent effects without concern for problems, in chromium treatment, of additional equipment installation, an increase in manufacturing costs and environmental pollution.

The present invention relates to a surface treatment composition comprising, on the basis of 100 wt % of the solid part of the composition, 20-40 wt % of a water-soluble polyurethane resin, 40-60 wt % of a silane-based sol-gel resin in which three types of silane compounds are cross-linked, 5-15 wt % of a curing agent, 0.5-1.5 wt % of a corrosion inhibitor, 0.1-1.0 wt % of a molybdenum-based compound, 1.0-3.0 wt % of a silane coupling agent; 1.0-2.0 wt % of an organometallic complex, 1.0-2.0 wt % of an acid scavenger, 0.1-1.0 wt % of an aluminum-based compound, and 1.0-2.0 wt % of a lubricant. A ternary hot-dip galvannealed steel sheet treated with a chromium-free surface treatment coating agent, according to an exemplary embodiment in the present invention, has excellent resistance to blackening, alkali and corrosion, and provides excellent effects without concern for problems, in chromium treatment, of additional equipment installation, an increase in manufacturing costs and environmental pollution.

Disclosed are an antimicrobial composition having excellent antimicrobial and anti-fungal properties and improved fingerprint resistance and chemical resistance, and a molded article including the same. The antimicrobial composition includes a combination of an amount of about 45 to 85 wt % of a polycarbonate resin, an amount of about 10 to 36 wt % of a polyester resin, an amount of about 3 to 12 wt % of an impact modifier, an amount of about 0.2 to 2 wt % of an inorganic antimicrobial agent, and an amount of about 1 to 6 wt % of a micro powder including a fluorine-based polymer resin, based on the total weight of the antimicrobial composition.

Disclosed are an antimicrobial composition having excellent antimicrobial and anti-fungal properties and improved fingerprint resistance and chemical resistance, and a molded article including the same. The antimicrobial composition includes a combination of an amount of about 45 to 85 wt % of a polycarbonate resin, an amount of about 10 to 36 wt % of a polyester resin, an amount of about 3 to 12 wt % of an impact modifier, an amount of about 0.2 to 2 wt % of an inorganic antimicrobial agent, and an amount of about 1 to 6 wt % of a micro powder including a fluorine-based polymer resin, based on the total weight of the antimicrobial composition.

A method of manufacturing a covered stent is disclosed. The method includes winding a first PTFE tape around a cylinder body of a jig, winding a second PTFE tape around a stent including the jig fitted therein, heating the stent in an oven, fitting the stent into upper and lower elastic members, fitting the elastic members into a mold, pressing the upper elastic member to bond the PTFE tapes to each other and to thus form a first film at a cylindrical body of the stent, taking the elastic members out of the mold, taking the stent out of the elastic members, removing the jig from the stent, forming a silicone coating layer at an expansion portion of the stent, and sewing the spaces in the expansion portion, the second PTFE tape, and the silicone coating layer to form a second film at the expansion portion.

A method of manufacturing a covered stent is disclosed. The method includes winding a first PTFE tape around a cylinder body of a jig, winding a second PTFE tape around a stent including the jig fitted therein, heating the stent in an oven, fitting the stent into upper and lower elastic members, fitting the elastic members into a mold, pressing the upper elastic member to bond the PTFE tapes to each other and to thus form a first film at a cylindrical body of the stent, taking the elastic members out of the mold, taking the stent out of the elastic members, removing the jig from the stent, forming a silicone coating layer at an expansion portion of the stent, and sewing the spaces in the expansion portion, the second PTFE tape, and the silicone coating layer to form a second film at the expansion portion.